The Relationship of Mitral Annulus Shape at CT to Mitral Regurgitation after Transcatheter Aortic Valve Replacement.


Journal

Radiology
ISSN: 1527-1315
Titre abrégé: Radiology
Pays: United States
ID NLM: 0401260

Informations de publication

Date de publication:
10 2021
Historique:
pubmed: 28 7 2021
medline: 12 10 2021
entrez: 27 7 2021
Statut: ppublish

Résumé

Background There are conflicting results over the improvement rate and predictors of mitral regurgitation in patients undergoing transcatheter aortic valve replacement (TAVR). Purpose To define the cause, degree of improvement, and improvement predictors of moderate to severe mitral regurgitation in patients undergoing TAVR by using a simplified D-shaped mitral annulus model derived from multisection CT (MSCT). Materials and Methods This retrospective cohort study included 528 consecutive patients who underwent TAVR between April 2012 and October 2019. Patients with previous surgical aortic valve replacement and those with moderate or severe mitral stenosis were excluded. A total of 104 patients with moderate to severe mitral regurgitation met the inclusion criteria and were included in the final analysis. At least one grade reduction in the severity of mitral regurgitation was considered indicative of mitral regurgitation improvement after TAVR. Up to 5-year post-TAVR follow-up of mitral regurgitation improvement was evaluated. Mitral annular dimensions (annular area, circumference, and trigone-to-trigone, intercommissural, and anteroposterior distances) and annular calcification were assessed at MSCT with use of dedicated postprocessing software. Associations with mitral regurgitation improvement after TAVR were explored. Results A total of 104 patients with concomitant mitral regurgitation who underwent TAVR (mean age, 74 years ± 7; 61 men) were included in the study. Mitral regurgitation improved in 79 patients after TAVR and remained unchanged in the remaining 25 patients. Maximum improvement was observed in the 1st year after TAVR. D-shaped mitral annular parameters, including annular circumference (odds ratio [OR], 1.05; 95% CI: 1.01, 1.1;

Identifiants

pubmed: 34313471
doi: 10.1148/radiol.2021210267
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

93-102

Commentaires et corrections

Type : CommentIn

Auteurs

Xi Li (X)

From the Department of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu 610041.

Abdullah Hagar (A)

From the Department of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu 610041.

Xin Wei (X)

From the Department of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu 610041.

Fei Chen (F)

From the Department of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu 610041.

Yijian Li (Y)

From the Department of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu 610041.

Tianyuan Xiong (T)

From the Department of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu 610041.

Yuanweixiang Ou (Y)

From the Department of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu 610041.

Zhengang Zhao (Z)

From the Department of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu 610041.

Qiao Li (Q)

From the Department of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu 610041.

Yong Peng (Y)

From the Department of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu 610041.

Hong Tang (H)

From the Department of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu 610041.

Yuan Feng (Y)

From the Department of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu 610041.

Mao Chen (M)

From the Department of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu 610041.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH